Key result
Quinapril reduces LV mass without impairing maximal exercise capacity in hypertensive models.
Why the study?
It was unclear whether reversal of left ventricular hypertrophy and associated afterload changes affect cardiovascular performance during exercise in spontaneously hypertensive rats.
Answers are grounded in this paper and cite their sources.
Supports clinical evaluation of quinapril for LV mass reduction; leaves open effects on exercise performance in patients.
OBJECTIVES: To investigate whether cardiovascular performance can be modified beneficially with left ventricular hypertrophy reversal and whether the associated sudden afterload increases may adversely affect overall cardiac performance. METHODS: We studied cardiovascular performance with thermodilution techniques at rest and during maximal treadmill exercise after 3 weeks' treatment with the angiotensin converting enzyme inhibitor quinapril (3 mg/kg per day) in 19 male spontaneously hypertensive rats (SHR) aged 20 weeks. RESULTS: Left ventricular mass was reduced significantly, without impairment of exercise performance, demonstrating that left ventricular hypertrophy reversal benefited or at least did not hinder cardiovascular adaptation to physiologic exercise in the SHR. Moreover, decreasing the afterload did not further improve the performance after the reversal of left ventricular hypertrophy.
No takes yet. Share an insight, caveat, or question.
Frohlich et al. (1994) studied Left ventricular hypertrophy in spontaneously hypertensive rats (n=19). Quinapril was evaluated on Cardiovascular performance at rest and during maximal treadmill exercise, and left ventricular mass. Three weeks of quinapril treatment significantly reduced left ventricular mass without impairing exercise performance in spontaneously hypertensive rats.
Synapse has enriched 10 related papers. Consider them for comparative context: